Type or extension of intestinal metaplasia and immature/atypical "indefinite-for-dysplasia" lesions as predictors of gastric neoplasia.
暂无分享,去创建一个
M. Ghigna | R. Fiocca | C. Klersy | O. Luinetti | E. Solcia | C. Fratti | C. Alvisi | E. Trespi | F. Tava | M. Perego
[1] E. Fontham,et al. Long term follow up of patients treated for Helicobacter pylori infection , 2005, Gut.
[2] F. Chan,et al. Factors predicting progression of gastric intestinal metaplasia: results of a randomised trial on Helicobacter pylori eradication , 2004, Gut.
[3] N. Yoshimura,et al. Progression of chronic atrophic gastritis associated with Helicobacter pylori infection increases risk of gastric cancer , 2004, International journal of cancer.
[4] S. Leung,et al. Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial. , 2004, JAMA.
[5] N. Sato,et al. Improvement of gastric atrophy after Helicobacter pylori eradication therapy. , 2003 .
[6] K. Chayama,et al. Helicobacter pylori eradication therapy improves atrophic gastritis and intestinal metaplasia: a 5‐year prospective study of patients with atrophic gastritis , 2002, Alimentary pharmacology & therapeutics.
[7] D. Graham,et al. Atrophic Gastritis and Intestinal Metaplasia in Japan: Results of a Large Multicenter Study , 2001, Helicobacter.
[8] L. Hansson,et al. Helicobacter pylori in gastric cancer established by CagA immunoblot as a marker of past infection. , 2001, Gastroenterology.
[9] N. Sasaki,et al. Helicobacter pylori infection and the development of gastric cancer. , 2001, The New England journal of medicine.
[10] G. Tagliabue,et al. The role of histological investigation in prognostic evaluation of advanced gastric cancer , 2001, Virchows Archiv.
[11] M. Gail,et al. Re: Chemoprevention of gastric dysplasia: randomized trial of antioxidant supplements and anti-helicobacter pylori therapy. , 2001, Journal of the National Cancer Institute.
[12] M. Blaser,et al. Gastric dysplasia and gastric cancer: Helicobacter pylori, serum vitamin C, and other risk factors. , 2000, Journal of the National Cancer Institute.
[13] D. Graham,et al. Topographic patterns of intestinal metaplasia and gastric cancer. , 2000 .
[14] M. Rugge,et al. Gastric dysplasia: the Padova international classification. , 2000, The American journal of surgical pathology.
[15] M. Fujishima,et al. Helicobacter pylori and Mucosal Atrophy in Patients with Gastric Cancer (A Special Study Regarding the Methods for Detecting Helicobacter pylori) , 1999, Digestive Diseases and Sciences.
[16] H. Nagai,et al. Helicobacter pylori infection induces gastric cancer in mongolian gerbils. , 1998, Gastroenterology.
[17] H. Watanabe,et al. Topographic distribution of Helicobacter pylori in the resected stomach , 1998, European journal of gastroenterology & hepatology.
[18] K. Haruma,et al. Effect of Helicobacter pylori eradication on subsequent development of cancer after endoscopic resection of early gastric cancer. , 1997, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[19] B. Marshall,et al. Long‐term follow‐up of gastric histology after Helicobacter pylori eradication , 1996, Journal of gastroenterology and hepatology.
[20] N. Muñoz,et al. Intestinal metaplasia types and the risk of gastric cancer: A cohort study in Slovenia , 1994, International journal of cancer.
[21] S. Tominaga,et al. A Prospective Study of Atrophic Gastritis and Stomach Cancer Risk , 1992, Japanese journal of cancer research : Gann.
[22] P. Blok,et al. Intestinal metaplasia and Helicobacter pylori: an endoscopic bioptic study of the gastric antrum. , 1992, Gut.
[23] G. Friedman,et al. Helicobacter pylori infection and the risk of gastric carcinoma. , 1991, The New England journal of medicine.
[24] M. Blaser,et al. Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii. , 1991, The New England journal of medicine.
[25] T. Rokkas,et al. Detection of an increased incidence of early gastric cancer in patients with intestinal metaplasia type III who are closely followed up. , 1991, Gut.
[26] E. Fontham,et al. Gastric precancerous process in a high risk population: cohort follow-up. , 1990, Cancer research.
[27] L. Villani,et al. Widespread expression of intestinal markers in gastric carcinoma: a light and electron microscopic study using BD-5 monoclonal antibody. , 1988, Journal of clinical pathology.
[28] P. Sipponen,et al. INTESTINAL METAPLASIA WITH COLONIC‐TYPE SULPHOMUCINS IN THE GASTRIC MUCOSA; ITS ASSOCIATION WITH GASTRIC CARCINOMA , 1980, Acta pathologica et microbiologica Scandinavica. Section A, Pathology.
[29] G. Stemmermann,et al. Intestinal metaplasia of the gastric mucosa: a gross and microscopic study of its distribution in various disease states. , 1968, Journal of the National Cancer Institute.
[30] H. Sugano,et al. Carcinoma of the stomach in incipient phase: its histogenesis and histological appearances. , 1968, Gan.
[31] D. Calistri,et al. Intestinal and diffuse gastric cancers arise in a different background of Helicobacter pylori gastritis through different gene involvement. , 1996, The American journal of surgical pathology.
[32] L. Villani,et al. High incidence of Helicobacter pylori colonization in early gastric cancer and the possible relationship to carcinogenesis , 1993 .